|The Chlamydia trachomatis n/a (Catalog #MBS530067) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The Chlamydia trachomatis antibody reacts with Chlamydia trachomatis and may cross-react with other species as described in the data sheet. MyBioSource\'s Chlamydia trachomatis can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Immunofluorescence (IF), Immunohistochemistry (IHC). Researchers should empirically determine the suitability of the Chlamydia trachomatis n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse monoclonal Chlamydia trachomatis antibody.
Biological Significance: Chlamydia trachomatis, an obligate intracellular human pathogen, is one of three bacterial species in the genus Chlamydia. C. trachomatis is a Gram-negative bacteria, therefore its cell wall components retain the counter-stain safranin and appear pink under a light microscope. In humans both sexes can display urethritis, proctitis (rectal disease and bleeding), trachoma, and infertility following infection with Chlamydia trachomatis. Biohazard Information: This product contains sodium azide as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.
Immunogen: Chlamydia trachomatis antibody was raised in mouse using MOMP as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Chlamydia trachomatis are readily searchable from our website. Different antibodies against the same target such as Chlamydia trachomatis may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.